Clinical Trial Update: Repeated High-dose Inhaled Corticosteroids for Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating repeated high-dose inhaled corticosteroids for asthma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Inhaled corticosteroids (high-dose) (corticosteroid, inhaled)

Snippet

Sponsor: University of Chicago | Conditions: Asthma | Phase 2 | Status: WITHDRAWN